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Mammalian females enter puberty with follicular reserves that exceed the number needed for ovulation during a single lifetime. Follicular
depletion occurs throughout reproductive life and ends in menopause, or reproductive senescence, when the follicle pool is exhausted. The
mechanisms regulating the production of a species-specific initial follicle pool are not well understood. However, the establishment of a follicular
reserve is critical to defining the length of reproductive cyclicity. Here we show that activin A (rh-ActA), a known regulator of follicle formation
and growth in vitro, increased the number of postnatal mouse primordial follicles by 30% when administered to neonatal animals during the time
of germline cyst breakdown and follicle assembly. This expansion in the initial follicle pool was characterized by a significant increase in both
germ cell and granulosa cell proliferation. However, the excess follicles formed shortly after birth did not persist into puberty and both adult rh-
ActA- and vehicle-treated animals demonstrated normal fertility. A follicle atresia kinetic constant (kA) was modeled for the two groups of
animals, and consistent with the empirical data, the kA for rh-ActA-treated was twice that of vehicle-treated animals. Kinetic constants for follicle
formation, follicle loss and follicle expansion from birth to postnatal day 19 were also derived for vehicle and rh-ActA treatment conditions.
Importantly, introduction of exogenous rh-ActA revealed an intrinsic ovarian quorum sensing mechanism that controls the number of follicles
available at puberty. We propose that there is an optimal number of oocytes present at puberty, and when the follicle number is exceeded, it occurs
at the expense of oocyte quality. The proposed mechanism provides a means by which the ovary eliminates excess follicles containing oocytes of
poor quality prior to puberty, thus maintaining fertility in the face of abnormal hormonal stimuli in the prepubertal period.
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Establishment and organization of the initial ovarian follicle
pool are critical to normal fertility in adult mammals. The
balance between germ cell, oocyte and primordial follicle
formation and persistence is essential for preventing excessive
germline loss leading to ovarian dysgenesis and premature
ovarian failure (Guigon and Magre, 2006). During mouse
embryonic development, gonadal structures called germline
133S.K. Bristol-Gould et al. / Developmental Biology 298 (2006) 132–148cysts are created within medullary cords (also termed sex cords
or ovigerous cords) surrounded by a basement membrane shortly
after primordial germ cells (PGCs) reach the genital ridge (10.5–
11.5 dpc) (McLaren, 2000) (Fig. 1). The PGCs, more
specifically termed oogonia in the female, cluster in the gonad
and multiply extensively for the next few days, with a generation
time of 15–16 h (Tam and Snow, 1981). The dividing oogonia
are held together by intracellular bridges as a result of
incomplete cytokinesis to form clonal clumps of 32 cells that
tend to go through mitosis synchronously (Gondos, 1973;
Pepling and Spradling, 1998) (Fig. 1). Around 13.5 dpc in the
female mouse, the first wave of oogonia enter meiosis and
eventually arrest as diplotene oocytes close to birth (Anderson
and Hirshfield, 1992; Evans et al., 1982; Peters, 1970). Im-
portantly, the onset of meiosis is not a synchronized event—
many oogonia continue to mitotically divide whereas others
enter meiotic prophase I (Evans et al., 1982). The intrinsic vs.
somatic cell-derived signals that influence the meiotic entry of
oogonia are areas of intense investigation.
Twenty-four hours after birth (19.5 dpc) in the mouse and
approximately 21 weeks of gestation in the human and
macaque, species-specific numbers of primordial follicles are
assembled from pre-existing germline cysts (Bayne et al.,
2004; Eddy et al., 1981; Francavilla et al., 1990; Konishi et
al., 1986; Pepling and Spradling, 1998, 2001; Van Wagenen
and Simpson, 1965). The transition of the germline cyst into
individual follicles occurs when the cysts undergo pro-
grammed breakdown (Fig. 1). A small fraction of selectedFig. 1. Schematic of germline cyst formation, breakdown and primordial follicle form
13.5 dpc. During cyst formation, mitotic division is accompanied by incomplete cy
Around 13.5 dpc, the first wave of oogonia within the cysts enter meiosis and arres
breakdown as somatic cells invade and begin to encapsulate individual oocytes into pr
followed by primordial follicle loss. dpc=days postcoitum, dpn=days postnatal.oocytes undergo a wave of atresia whereas the surviving
oocytes become surrounded by proliferating somatic cells
(pregranulosa cells) that invade the cyst, divide the
cytoplasm and eventually guide the separation of oocytes
to form individual follicles (Hirshfield, 1991; Pepling and
Spradling, 2001). Associated with meiotic prophase and
continuous with cyst breakdown is a massive loss in germ
cell number (Borum, 1961; McClellan et al., 2003; Pepling
and Spradling, 2001; Prepin et al., 1985). The factors that
control this balance of germ cell loss with the number of
postnatal follicles that emerge from the starting pool of germ
cells are not known. Moreover, how initial follicle numbers
impact adult fertility has not been fully explored in the
mouse.
Steroid and peptide hormones, as well as endocrine
disruptors, control or interrupt adult follicle maturation and
selection and are therefore good candidate modulators of the
initial follicle pool. One peptide hormone known to be
involved in mouse and human follicle formation in vitro is
activin. Activin and its receptors are expressed in the genital
ridge at the time of germ cell colonization and proliferation
(Feijen et al., 1994), and the XX gonad expresses the activin
antagonist inhibin B in the 12.5 dpc mouse (Yao et al., 2006).
Activin has been shown to organize two-dimensional mouse
follicles from monolayer cultures of granulosa cells and
oocytes in vitro, and these structures are able to synthesize
both steroid and peptide hormones (Li et al., 1995).
Additionally, activin promotes germ cell proliferation prioration. Following PGC arrival at the gonad, germline cysts form between 10.5 and
tokinesis so that the daughter cells remain connected by intercellular bridges.
t at the end of prophase I. Approximately 24 h after birth, these cysts begin to
imordial follicles. Coincident with cyst breakdown is an initial loss of germ cells
134 S.K. Bristol-Gould et al. / Developmental Biology 298 (2006) 132–148to the formation of primordial follicles in human fetal
ovarian cortical cultures, making it a potential regulator of
the earliest events in the ovary (Martins da Silva et al., 2004).
Accordingly, loss of activin through gene knockout, receptor
elimination or overexpression of dominant-negative cytoplas-
mic co-regulators results in gonadal dysgenesis or inappropri-
ate follicle function (Bristol-Gould et al., 2005; Brown et al.,
2000; Matzuk et al., 1995; McMullen et al., 2001). Lastly,
activin is a potent regulator of cell cycle progression and
differentiation in a variety of tissues including the breast,
ovary and prostate (Burdette et al., 2005; Dowling and
Risbridger, 2000; El-Hefnawy and Zeleznik, 2001; Ogawa et
al., 2003; Reis et al., 2004). Therefore, we predicted that
activin may regulate the number of follicles formed from
germline cysts in vivo in the mouse during the critical period
of germline cyst breakdown and follicle formation.
The population of follicles present in the ovary on postnatal
day 6 represents the total number of oocytes that were
encapsulated by pre-granulosa cells and is the total population
available to the female, at least until puberty. Recent studies
suggest that adult germ cells may be derived from stem cells
recruited from the bone marrow and this cohort, not the initial
follicle pool, drives fertility later in life (Johnson et al., 2005).
Interestingly, activin is also known to induce stem cell
differentiation in murine bone marrow cultures (Gaddy-Kurten
et al., 2002). To determine whether the initial follicle pool can
be manipulated hormonally, and to establish the effect of activin
on germ cell proliferation, follicle formation and possible stem
cell recruitment, neonatal mice were treated with recombinant
human Activin A (rh-ActA) during the critical period of
germline cyst breakdown and initial follicle assembly. We then
explored changes in postnatal follicle number, oocyte health
status and the impact on adult fertility.
Lastly, we developed a mathematical model to substantiate
results obtained from rh-ActA injection experiments and to
describe germ cell/early follicle dynamics. For the first time, our
study design permitted us to describe rates of follicle formation,
loss, expansion and atresia during neonatal life in an untreated
mouse ovary and compare these values to rh-ActA-treated
mouse ovaries. Taken together, our empirical data and
mathematical modeling suggest that the initial follicle pool
can be regulated by activin during the critical period of germline
cyst breakdown and primordial follicle assembly; however,
significant alterations to the follicle pool caused by exogenous
activin are restored by puberty via an intrinsic ovarian quorum
sensing mechanism.Materials and methods
Animals
CD1 mice were maintained in accordance with the policies of the
Northwestern University's Animal Care and Use Committee. Mice were
housed, injected and bred in a controlled barrier facility within Northwestern
University's Center of Comparative Medicine (Evanston, IL). Temperature,
humidity and photoperiod (12L, 12D) were kept constant. Mice were fed a
phytoestrogen-free diet (Harlan Teklad Global 2019 or Harlan Teklad Breeder
diet 2919, Harlan Teklad, Madison, WI).Tissue processing and follicle counting
Vehicle- and rh-ActA-treated animal ovaries were fixed for 14 h in 4%
paraformaldehyde and processed for paraffin embedding. Ovaries were
completely serial sectioned and stained for counting. Based on several
approaches by others, we developed a rigorous counting method (Canning et
al., 2003; Durlinger et al., 1999; Flaws et al., 2001; Johnson et al., 2004; Pepling
and Spradling, 2001; Ratts et al., 1995). Two or more individuals counted 5 μm
serial sectioned ovaries collected on postnatal days 0 (19.5 dpc), 6, 10 and 19.
The investigators were blinded to treatment condition or group. Follicles were
counted in every 5th section throughout the entire ovary (for a discussion of the
importance of counting multiple sections, see McClellan et al., 2003). Postnatal
day 0 ovaries were stained for germ cell nuclear antigen 1 (GCNA-1, a gift from
Dr. George Enders, University of KansasMedical Center; Enders andMay, 1994)
in order to visualize and count germ cell nuclei within a cyst. On postnatal days 6,
10 and 19, all follicle types were categorized by morphological criteria.
Primordial follicles were classified as an oocyte partially surrounded by either
squamous granulosa cells or an oocyte partially surrounded by squamous and
cuboidal granulosa cells. Large numbers of morphologically unhealthy
primordial follicles were not observed, so all follicles were counted. Primary
follicles contained a small oocyte completely surrounded by a single layer of
cuboidal granulosa cells. All primordial and primary follicles were counted,
regardless of the presence or absence of the oocyte nucleus. Secondary follicles
contained a larger oocyte and more than one layer of granulosa cells, with theca
cells often present. Tertiary (small antral) follicles were similar in size to
secondary follicles but included an antrum. Antral follicles were the largest
follicles and contained large antral spaces. Only morphologically healthy
secondary, tertiary and antral follicles were counted. Additionally, only sections
in which an oocyte nucleus was present were counted to prevent double counting.
The number of follicles per ovary was summed for each observer and that
total was averaged. The average number of follicles per ovary was then divided
by the number of sections counted in order to calculate follicles per section for
each follicle population. Because every 5th section was counted, a correction
factor was applied to adjust for the counting rules and the size of the ovary (as
ovarian size varied with the age of the animal). To obtain the correction factor for
serially sectioned ovaries at each time point, we determined a total standard
average section number for each time point. For secondary, tertiary and antral
follicles, follicles were only counted if the oocyte nucleus was present in the
section. Therefore, these follicles could not be double counted and the follicles
per section was multiplied by the average section numbers (see Table 1). On
postnatal day 0, germ cell nuclei averaged 7 μm in size. Therefore, the same
nucleus would be detected every 1.5 sections and the average section number
was divided by 1.5 (Table 1). For postnatal days 6, 10 and 19, the primordial and
primary follicles were counted whether or not the oocyte nucleus was present.
The oocyte diameter for these small follicles averaged 14 μm; therefore, the
same follicle would be counted every 2 sections. In order to prevent double
counting of these small follicles the average section number was divided by 2 to
obtain the normalization factor for these two follicle classes (Table 1). These
correction factors were necessary in order to compare follicle pools between
time points and to obtain a whole ovary, and then whole animal (×2), value.
Follicle counts were comparable to previous reports using stereological
approaches after strain differences were taken into account (Myers et al.,
2004). Germ cell counts in CD1 mice on the day of birth were remarkably
similar to those obtained in CBA/Ca mice (Faddy et al., 1987).
Activin clearance and targeting
Postnatal day 4 animals were treated with [125I] rh-ActA to determine ligand
clearance and targeting in the ovary. 0.5 h before treatment with iodinated
hormone, animals received 50 mg sodium iodide to minimize non-specific
uptake of 125I. 60 μg/kg of [125I] rh-ActAwas subcutaneously injected into each
pup (n=3 for each time point). At various times, serum and ovaries were
collected. Serum was run on a 12% SDS–PAGE gel, dried and exposed to film
in order to obtain hormone clearance information. Five-micrometer serial
sections of ovaries were cut using a microtome and slides were dipped in NTB2
emulsion (Eastman Kodak, New Haven, CT) and kept in the dark for 1 month.
Following emulsion coating, slides were developed using D-19 Developer
(Eastman Kodak, New Haven, CT) and Fixer (Eastman Kodak, New Haven,
Table 1
Normalization factors and follicle counts for vehicle- and rh-ActA-treated CD1 mice
Age
(days)
n=ovaries Normalization Number of germ cell nuclei or follicles per animala
GCN/PF/1° 2°/3°/Antral GCN PF 1° 2° 3° Antral
0 10 26.7 N/A 16788±1384 N/A N/A N/A N/A N/A
Vehicle
6 11 37.5 75 N/A 10,265±489 414±29 447±49 N/A N/A
10 8 50.0 100 N/A 8662±660 567±82 984±85 10±6 N/A
19 6 62.5 125 N/A 5127±488 294±21 656±74 293±21 20±5
rh-ActA
6 12 37.5 75 N/A 13,009±815b 417±30 542±80 N/A N/A
10 10 50.0 100 N/A 11,689±771b 440±52 1118±90 6±3 N/A
19 10 62.5 125 N/A 4794±440 304±31 501±54b 321±43 44±9b
aData are given as average±SEM. Abbreviations used: GCN=germ cell nuclei, PF=primordial follicle, 1°=primary follicle, 2°=secondary follicle, 3°= tertiary
follicle, N/A=not applicable. bSignificantly different than vehicle, p<0.05.
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using a Leica DM5000 microscope and acquired using OpenLab software
(Improvision, Lexington, MA).
Hormone measurements
Serum FSH was measured by radioimmunoassay (RIA, Ligand Assay and
Analysis Core Laboratory, Center for Research in Reproduction, University of
Virginia, Charlottesville, VA). The FSH RIA had a detection range of 3.5–
30.7 ng/ml. The average intra-assay and inter-assay coefficients of variation
were 4.6% and 14.4%, respectively.
Immunohistochemistry
Mouse ovaries were placed in 4% paraformaldehyde (Sigma, St. Louis, MO)
fixative for 8–14 h. The tissue was then dehydrated and paraffin embedded. Five-
micrometer sections were cut with a microtome and mounted on Superfrost-Plus
slides (Vector Laboratories, Inc., Burlingame, CA). Slides were deparaffinized in
xylene and then rehydrated in a series of ethanol. Antigen retrieval (heat in
microwave on high for 7 min, low for 2 min) was performed in 10 mM sodium
citrate pH 6 followed by cooling in antigen retrieval solution for 20 min. Slides
were washed in Tris-buffered saline–Tween (TBS-T) to permeabilize cell
membranes, then incubated in 3% hydrogen peroxide in TBS for 15 min.
Endogenous avidin and biotin were blocked using the Avidin–Biotin Blocking
Kit (Vector Laboratories, Inc., Burlingame, CA) for 15 min each. This was
followed by blocking for 1 h in 10% serum (from the host of secondary antibody)
in 3% bovine serum albumin–TBS (BSA–TBS) at room temperature. Sections
were incubated overnight in primary antibody diluted in the block solution. The
following day, the slides were rinsed in TBS-T and incubated in secondary
antibody conjugated to biotin (Vector Laboratories, Inc., Burlingame, CA) in 3%
BSA–TBS for 30 min to 1 h. Slides were rinsed in TBS-T prior to adding ABC
reagent (Vector Laboratories, Inc., Burlingame, CA) for 30 min. Finally, DAB
substrate (Vector Laboratories, Inc., Burlingame, CA) was added for 3 min, the
reaction stopped for 5 min in ddh2O and the slides were counterstained with
hematoxylin. Immunohistochemical images were acquired on a Nikon E600
microscope using a Spot Insight Mosaic 11.2 color digital camera (Diagnostic
Instruments, Sterling Heights, MI) and ADVANCED SPOT IMAGING software
(Version 4.6, Universal Imaging, Downington, PA).
Antibodies
The antigens detected by immunohistochemistry were the activin βA- and
βB-subunits; the activin receptors ActRIB, ActRIIA, ActRIIB; Smad3; germ cell
nuclear antigen 1 (GCNA1); stage-specific embryonic antigen 1 (SSEA-1); and
B cell leukemia/lymphoma 2 (BCL-2). The primary antibodies used were rabbit
polyclonal anti-βA- and βB-subunit antibodies (a gift from W. Vale and J.
Vaughn, The Salk Institute, La Jolla, CA); goat polyclonal antibodies purchasedfrom R&D Systems (Minneapolis, MN) directed against ActRIB, ActRIIA and
ActRIIB; a rabbit polyclonal anti-Smad3 antibody purchased from Zymed
Laboratories (South San Francisco, CA); mAb 10D9G11 rat IgM that recognizes
GCNA1 (gift from Dr. George Enders, University of Kansas Medical Center,
Kansas City, Kansas); a mouse anti-SSEA-1 monoclonal antibody (Chemicon
International, Temecula, CA); and a mouse anti-human BCL-2 monoclonal
antibody (DakoCytomation, Denmark). Dilutions of the primary antibodies
against the βA- and βB-subunits, ActRIB, ActRIIA, ActRIIB, Smad3, GCNA1,
SSEA-1 and BCL-2 were 1:100, 1:100, 1:10, 1:25, 1:25, 1:100, neat, 1:50 and
1:50, respectively. The secondary antibodies used were biotinylated rabbit anti-
goat, biotinylated goat anti-rabbit or biotinylated rabbit anti-rat (Vector
Laboratories, Inc., Burlingame, CA). Because SSEA-1 and BCL-2 were
monoclonal antibodies, the secondary antibody from the M.O.M.™ Immuno-
detection Kit (Vector Laboratories, Inc., Burlingame, CA) was used. DAB
substrate was applied followed by hematoxylin counterstaining. All negative
controls were included by omitting the primary antibody.
Identification of proliferating and apoptotic cells
Proliferating cell nuclear antigen (PCNA) was stained by immunofluores-
cence using a PCNA staining kit (Zymed Laboratories, South San Francisco,
CA). For immunofluorescent detection, the TSA™-Plus Fluorescein System
(Perkin Elmer Life Sciences, Boston, MA) was used via deposition of an FITC-
labeled tyramide proximal to the HRP enzyme site. TUNEL staining was
performed using the DeadEnd™ Fluorometric TUNEL System Kit following
the manufacturer's protocol (Promega Corporation, Madison, WI). Slides were
mounted with Vectashield containing DAPI (Vector Laboratories, Inc.,
Burlingame, CA). Immunofluorescent images were acquired on a Nikon E600
microscope using a Spot RT monochrome digital camera (Diagnostic
Instruments, Sterling Heights, MI) and Metamorph Imaging Software (Version
4.9; Universal Imaging, Downington, PA).
Counting of PCNA immunopositive cells
Total oocytes and total granulosa cellswere counted in 3different fieldswithin
1 section of several ovaries (vehicle n=4, rh-ActA n=5). The number of cells
countedineachfieldwassimilar.Subsequently,PCNA-positivecellswerecounted
in the samefieldsand thepercentageofpositivecellsoutof the totalwascalculated.
In vivo ovulation (IVO)
IVO was induced on postnatal day 21 or 54 in rh-ActA- and vehicle-treated
animals. Animals were primed with 5 IU of PMSG and then induced to ovulate
with 5 IU of hCG 48 h later. Intact cumulus–oocyte complexes were collected
from the thin walled portion of the oviduct 14 h after hCG treatment and briefly
incubated in 200 μg/ml hyaluronidase to release the oocytes. Oocytes were
classifiedmorphologically based on the presence or absence of a germinal vesicle
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fragmented or shrunken from the zona pellucida. Images were captured on an
inverted Leica DM IRB microscope (Leica, Bannockburn, IL) equipped with a
Photometrics CoolSNAP fx camera (Roper Scientific, Tucson, AZ) andMetaVue
5 image software (Universal Imaging Corporation, Downingtown, PA). Two
diameters were measured for each oocyte and averaged to determine oocyte size.
Oocytes were then fixed and processed for immunofluorescence as previously
described (Hodges et al., 2002). Oocytes were stained with a 1:400 dilution of
monoclonal anti-α-tubulin (Sigma, St. Louis, MO), followed by a 1:500 dilution
of AlexaFluor 488 goat anti-mouse antibody (Molecular Probes, Eugene, OR)
and mounted in VectaShield with DAPI (Vector Laboratories, Inc., Burlingame,
CA) to examine the meiotic spindles. Immunofluorescent images were acquired
on a Nikon E600 microscope using a Spot RT monochrome digital camera
(Diagnostic Instruments, Sterling Heights, MI) and Metamorph Imaging
Software (Version 4.9; Universal Imaging, Downington, PA). Spindles were
classified for congression failure and tubulin morphology by two independent
observers who were blinded to the treatment condition and group [n=32–61
metaphase I (MI) or metaphase II (MII) oocytes per treatment for postnatal day 24
IVO; n=8–52 MI or MII oocytes per treatment for postnatal day 57 IVO].
Statistical analysis
Comparisons for follicle counts, number of oocytes ovulated, oocyte
diameter and percentage of PCNA-positive cells were made between rh-ActA
and vehicle treatment groups using a two-way t test, with p<0.05 considered
statistically significant. The percentage of MII class oocytes, PCNA-positive
cells and comparisons for tubulin and chromosome morphologies were
analyzed using Fisher's exact test, with p<0.05 considered statistically
significant. All statistical calculations were carried out with the software
package JMP 4.0.4 (SAS Institute, Cary, NC). Data are represented in figures as
average±SEM.
Mathematical model of germ cell and follicle dynamics
Germ cell (G) and follicle (F) dynamics are described by Eqs. (1) and (2)
below. Transitions between states were modeled with first-order kinetics. The
initial pool of germ cells (G°) either (i) are lost (kL), (ii) form follicles (kF) or (iii)
proliferate and expand the germ cell pool (kE). The dynamics of germ cell loss
and follicle formation in CD1 mice have been previously characterized (Pepling
and Spradling, 2001). Briefly, individual follicles began to appear shortly after
birth, and a reduction in the germ cell pool was observed through 22.5 dpc
(postnatal day 3). The transition from germ cells to follicles was essentially
completed by 25.5 dpc (postnatal day 6). After 25.5 dpc (postnatal day 6),
follicles are depleted from the ovary by a process termed atresia (kA). Equations
were solved numerically using an ordinary differential equation solver in Matlab
(The Mathworks, Inc., Natick, MA). Total follicle counts were used to fully
account for the fate of all germ cells, as counting only primordial follicles would
artificially lower the germ cell count by neglecting those germ cells that form
primordial follicles and subsequently transition to primary and secondary
follicles during this time frame.
dG
dt
¼ kLG kFGþ kEG; ð1Þ
dF
dt
¼ kFG kAF: ð2Þ
Follicle loss following the completion of germ cell depletion and follicle
formation was modeled assuming first-order kinetics. Under these constraints,
Eq. (2) simplifies to Eq. (3). Total follicle counts for postnatal days 6, 10 and 19
(Table 1) were log transformed and fit to the linearized solution using GraphPad
Prism 4.0 (GraphPad Software, San Diego, CA). Values for the follicle loss
kinetic parameter (kA) were significantly greater for rh-ActA-treated animals
compared with vehicle-treated animals (p<0.05) based on the statistical




Activin subunit and receptor localization in neonatal mice
Prior to beginning the injection study, the presence of the
activin βA- and βB-subunits, as well as the activin receptors,
was examined in the neonatal mouse ovary. Ovaries from
postnatal days 0 to 4 were sectioned and immunostained to
determine protein localization. Immunostaining of the activin
subunits, βA (Figs. 2A, B) and βB (Figs. 2C, D), was robust
on all days examined within both somatic cells and oocytes
(only days 0 and 4 are shown because similar patterns were
detected on all days). Continuous staining observed in the
postnatal day 0 ovaries indicated localization within the
germline cyst (Figs. 2A and C). By postnatal day 4, the brown
stain appeared more discrete, with some protein localizing to
the oocyte, but more apparent staining within the granulosa
cells surrounding the oocytes (Figs. 2B and D, red boxes). Of
note, the first follicles that form as a result of the germline cyst
breakdown process appear by postnatal day 4. Thus, the
overall localization pattern provides convincing evidence that
activin subunits are present in the neonatal ovary during
germline cyst breakdown.
The activin receptors (ActRIB, ActRIIA and ActRIIB) were
also localized to the oocyte and granulosa cells on postnatal
days 0–4. Fig. 3 depicts magnified images of receptor staining
on postnatal day 4, which show localization patterns similar to
that of the activin subunits (Figs. 3A–C). In addition, the activin
receptors were also present in the ovarian surface epithelium
(OSE; Figs. 3B, C, arrows). Based on these data, neonatal
mouse ovaries are potentially activin-responsive.
Pharmacokinetic analysis, serum FSH measurements and
induction of the activin signaling pathway in rh-ActA-treated
animals
Female mice were injected with rh-ActA from birth through
the completion of germline cyst breakdown. Rh-ActA was
delivered for 4 consecutive days by subcutaneous administra-
tion every 4 h beginning within the first 3 h of life. A timeline
depicting the neonatal injection schedule and subsequent
experiments performed throughout this study is provided in
Fig. 4. The rh-ActA injection scheme was designed to target
the time during which cyst breakdown occurred and primordial
follicle formation was initiated. Activin is known to be
hepatotoxic when delivered continuously; therefore, this
injection strategy was developed based on previous pharma-
cokinetic studies (Woodruff et al., 1993a,b) to avoid activin
accumulation. At 10 min, 30 min and 45 min after injection of
iodinated rh-ActA, animals were sacrificed and serum and
ovaries were collected (Fig. 5A). Serum was run on a gel and
exposed to film to determine the presence of iodinated rh-
ActA in the serum. By 45 min, no bands were present on the
film; therefore, rh-ActA cleared from the neonatal pup
circulation within 30–45 min. To determine if rh-ActA had a
direct effect on the ovary, the collected ovaries were sectioned,
exposed to emulsion and developed. Rh-ActA targeted the
Fig. 2. Activin subunit localization in neonatal mouse ovaries. βA-subunit immunostaining on postnatal days 0 and 4 (A, B), respectively, and βB-subunit
immunostaining on postnatal days 0 and 4 (C, D), respectively. Protein is localized in the oocyte and granulosa cells in contact with an oocyte. Staining appears
continuous as labeling is evident in oocytes within the germline cysts (A and C). By postnatal day 4, the staining appears more discretely in distinct primordial follicle
units; by this time, cyst breakdown has occurred and the initial follicle population is present. Postnatal day 4 negative control in which the βA-subunit primary antibody
was omitted (E). Adult ovary stained for βA-subunit to indicate specificity of this antibody for granulosa cells (F). Scale bars: 25 μm (A–E) and 100 μm (F).
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10 min of administration (Fig. 5B).
In order to determine if rh-ActA impacted pituitary
function, and therefore indirectly acted on the ovary, serum
FSH levels were measured in pups injected with rh-ActA or
vehicle on postnatal days 2, 6, 10 and 19. No differences in
FSH levels were measured in those animals treated with rh-
ActA or vehicle, suggesting that exogenous rh-ActA was not
acting on the pituitary (Fig. 6A). A characteristic rise in
serum FSH was measured on day 10 as described in earlier
studies of serum FSH levels in immature female mice and rats
(Ackland and Schwartz, 1991; Michael et al., 1980; Rebar et
al., 1981). To verify the fact that rh-ActA was bioactive in
vivo, Smad3 immunoreactivity was measured. Higher levels
of nuclear Smad3 were detected in ovaries from rh-ActA-
treated animals compared with vehicle-treated animals (Figs.
6B and C). These data indicate that the exogenous ligand not
only targeted the ovary but also activated the activin signaling
pathway.Regulated assembly of the initial follicle pool from germline
cysts
To quantitate the baseline number of germ cells present prior to
germ cell loss associated with cyst breakdown and follicle
formation, GCNA-1 stained nuclei were counted in serially sec-
tioned postnatal day 0 mouse ovaries (Fig. 7). GCNA-1 is a
marker of germ cell nuclei, produced until the oocyte arrests in
diplotene. A manual counting method (see Materials and
methods) was developed to accurately quantify germ cells or
follicle populations in an ovary. 16,788±1384 germ cell nuclei
per animal were present in the ovaries of CD1 mice at birth
(19.5 dpc, postnatal day 0). By postnatal day 6, few germline
cysts were observed and the ovaries contained primarily follicles.
At this time, there were 10,265±489 primordial follicles per
animal, 414±29 primary follicles per animal and 447±49
secondary follicles per animal (11,126±504 total follicles). This
represents a transition of 66% of the initial germ cell cohort into
follicles and a 33% loss of germ cells by postnatal day 6 (Table 1).
Fig. 3. Activin receptor localization in neonatal mouse ovaries. Activin receptor staining appears localized in a similar manner as that observed for the activin subunits.
Postnatal day 4 ovaries immunostained for ActRIB, ActRIIA and ActRIIB, respectively (A–C). The staining is localized in discrete primordial follicles (red boxes).
Receptor staining also appears in the OSE of these neonatal ovaries (arrows). Postnatal day 4 negative control in which the ActRIB receptor primary antibody was
omitted (D). Scale bar: 25 μm (A–D).
138 S.K. Bristol-Gould et al. / Developmental Biology 298 (2006) 132–148To examine whether activin regulates follicle assembly,
ovaries from rh-ActA injected animals were collected at various
intervals following hormone administration and the number and
type of follicles were measured (Table 1, Fig. 8). Rh-ActA-Fig. 4. Neonatal injection study design. Germ cell mitosis and meiosis are processes th
cysts of interconnected germ cells form by incomplete cytokinesis; shortly after bi
encapsulated by pre-granulosa cells. At approximately 12 months of age, mice usually
The red font indicates the days on which germ cell or follicle counts were acquiredtreated ovaries collected on postnatal day 6 had 13,009±815
primordial follicles (Figs. 8B and D), a 27% increase in this
category compared with vehicle-treated ovaries (10,265±489)
(Figs. 8A and C). The primordial follicles were distributedat take place mainly in the embryonic ovary in the mouse. Prior to birth, germline
rth, programmed breakdown of these cysts occurs and individual follicles are
show a decrease in fertility due to exhaustion of their ovarian follicular reserve.
(birth, postnatal days 6, 10 and 19).
Fig. 6. Serum FSH and Smad3 protein localization. (A) FSH levels in animals of
both treatments groups were measured. No significant differences were found
using a two-way t test (p<0.05). Immunolocalization of Smad3 protein in
ovaries of postnatal day 10 vehicle- (B) and rh-ActA-treated (C) animals. A
higher intensity of nuclear Smad3 staining was detected in ovaries from the rh-
ActA treatment group.
Fig. 5. Pharmacokinetic profile and ligand targeting. (A) At 10 and 30 min after
injection, [125I] rh-ActA is detected in the serum of pups. At 45 min, activin
bands are no longer visible. (B) Neonatal ovaries were processed and paraffin
embedded to visualize hormone targeting. [125I] rh-ActA appears to be localized
within the somatic cell compartment (shown at 10 min after injection).
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tissue (Figs. 8C, D). The increase in the initial follicle pool on
postnatal day 6 persisted through postnatal day 10, with 35%
more primordial follicles present in rh-ActA-treated animal
ovaries compared with vehicle-treated animal ovaries (vehicle,
8662±660 vs. rh-ActA, 11689±771; Figs. 8E–H). There were
no significant differences in the number of primary, secondary or
tertiary follicles between treatment groups on postnatal days 6
and 10 (Table 1).
Mechanism of primordial follicle pool expansion
To examine the mechanism by which rh-ActA treatment led
to a significant expansion of the primordial follicle pool in
postnatal mice, we tested whether rh-ActA treatment was
accompanied by a decrease in cell apoptosis, an increase in
proliferation or cell survival or whether rh-ActA recruited
germline stem cells to the developing ovary at day 2. Similar to
previous studies (Fenwick and Hurst, 2002; Pepling and
Spradling, 2001), apoptosis (detected by TUNEL staining)
was detectable but at very low levels and was not affected by rh-
ActA treatment (Figs. 9A–H). The number of FITC-labeled
cells was similar between treatment groups. Thus, rh-ActA did
not appear to rescue germ cells destined to undergo apoptosis inthe postnatal ovary. Conversely, rh-ActA caused a significant
increase in granulosa cell and germ cell proliferation (Figs. 9I–
P). We used PCNA, a protein synthesized in early G1 and S
phases of the cell cycle, to localize those cells undergoing
mitotic activity (counting methods described in Materials and
methods). Rh-ActA-treated animals had a 2-fold higher number
of PCNA positive somatic cells compared with vehicle-treated
animals (42% vs. 23%, p<0.001), suggesting that one
mechanism by which rh-ActA regulated follicle number was
to increase the number of somatic cells that can encapsulate
individual germ cells. Additionally, there was an 8-fold increase
in the number of germ cells that were PCNA positive in the
ovaries of rh-ActA-treated vs. vehicle-treated animals (40.2%
vs. 4.8%, p<0.001). The low level of germ cell mitotic activity
measured in postnatal vehicle-treated animals (4.8%) was
comparable to the postnatal level of mitosis observed in
previous studies in the hamster (Arrau et al., 1981). Moreover,
the rh-ActA effect on germ cell proliferation confirms and
extends studies performed on in vitro-grown human fetal
ovarian cortical tissue, in which activin induced germ cell
proliferation (Martins da Silva et al., 2004).
Fig. 7. Germ cell nuclear antigen 1 (GCNA-1) immunostaining. GCNA-1
immunostained ovary at birth (19.5 dpc/postnatal day 0). GCNA serves as a
marker of germ cell nuclei until they reach the diplotene stage of the first meiotic
division at which time expression is lost. This marker was used to aid in day 0
counting of germ cell nuclei (Table 1).
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germline stem cells in the repopulation of the primordial
follicle pool in the adult ovary (Johnson et al., 2005), we also
examined whether rh-ActA induced the recruitment of germline
stem cells into the neonatal ovary using the carbohydrate
epitope stem cell marker, SSEA-1. No evidence of SSEA-1
staining in vehicle- or rh-ActA-treated ovaries on postnatal day
2 was found (Figs. 10A and B), suggesting that recruitment of
stem cells to the neonatal ovary was not responsible for the
increase in the initial primordial follicle pool (in the
accompanying paper, no germ cell specific SSEA-1 staining
was detected in the adult ovary; Bristol-Gould et al. (this issue)).
Finally, the possibility that activin increases follicle survival
was examined by anti-apoptotic protein, BCL-2 staining. BCL-
2 was found to be highly expressed in the ovary and localized to
the oocyte cytoplasm in all follicles, regardless of treatment
(Figs. 10C and D). Thus, the mechanism by which activin
increases primordial follicle number appears to be stimulation
of mitosis in both the somatic cell and germ cell compartments,
although we were not able to completely rule out activin
inhibition of a mechanism of oocyte loss that does not depend
on the BCL-2/BAX pathway.Effect of rh-ActA on oocyte quality and post-pubertal fertility
By postnatal day 19, the number of primordial follicles in rh-
ActA-treated animals was restored to the same levels as that of
animals treated with vehicle (Table 1). Rh-ActA-treated ovaries
contained significantly fewer secondary follicles, but signifi-
cantly more antral follicles, compared with vehicle-treated
ovaries. Despite the large primordial follicle pool on postnatal
days 6 and 10, there were no corresponding increases in the
number of later stage follicles, indicating that by postnatal day
19, the ovary appeared to compensate for the excess follicle
burden established by rh-ActA administration. These data are
similar to previous studies, which illustrated that mouse strain
differences in initial follicle number are not maintained in the
adult animal (Canning et al., 2003). Additionally, mice that
overexpress BCL-2 have an increased number of primordial
follicles at birth that are not preserved in later stages of postnatal
life (Flaws et al., 2001).
Oocyte quality and adult fertility was further explored to
determine whether hormonal modulation of the initial follicle
pool impacted these parameters. Immature mice treated with
either vehicle or rh-ActA were induced to ovulate on postnatal
day 24 with exogenous gonadotropins (in vivo ovulation, IVO).
Mice treated with rh-ActA had a significantly higher number of
oocytes ovulated on postnatal day 24 relative to mice that
received vehicle treatment (Fig. 11A, p<0.05). However,
ovulated oocytes from animals treated with rh-ActA were less
mature, as fewer of these oocytes had advanced to MII (MII %,
Fig. 11A, p<0.05) and the oocytes had significantly smaller
diameters (7.5% smaller for MI, 10.4% smaller for MII,
p<0.01) as compared with oocytes ovulated from vehicle-
treated ovaries. Furthermore, when these oocytes were stained
for α-tubulin and chromatin, a significantly higher number of
the oocytes from rh-ActA-treated mice displayed an excess of
tubulin scatter (tubulin spraying away from the spindle body) at
the MI stage (Figs. 11B–D). Chromosome alignment was not
significantly affected by either treatment (DAPI stain at
metaphase plate; Figs. 11C–E). Thus, although rh-ActA-treated
mice had a larger number of oocytes that ovulated, oocyte
quality (as assessed by oocyte diameter, percentage reaching
MII and tubulin scatter) was poor.
To examine the impact of rh-ActA treatment on the initial
follicle pool and how it relates to adult fertility, fecundity
measurements were taken in mice that were treated in with rh-
ActA or vehicle. Based on the oocyte quality findings from the
IVO study described above, it was expected that fertility might
be affected in the rh-ActA-treated animals. However, rh-ActA-
treated animals displayed no significant differences in either the
birthing frequency (rh-ActA, 1.2 litters/month vs. vehicle, 1.2
litters/month) or litter size (rh-ActA, 15.9±0.6 pups vs. vehicle,
14.9±1.0 pups) over a 5-month period. These data suggest that
by the time of adulthood, and perhaps puberty, poor quality
oocytes in the rhActA-treated mice had been eliminated from
the ovary.
To test this conclusion directly, treated mice were induced to
ovulate at postnatal day 57, which corresponds to the initiation
of the breeding study, and gamete quality was tested. There
Fig. 8. Ovarian morphology. On postnatal days 6 and 10, there were significantly more primordial follicles (27% and 35%more respectively) in ovaries from rh-ActA-
treated mice (A–H). The higher primordial follicle number was observed in cortical regions of ovaries from rh-ActA-treated animals (D, H) compared with those from
vehicle-treated animals (C, G) (indicated in red). Scale bars: 100 μm (A, B, E, F) and 50 μm (C, D, G, H).
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ovulated, the percentage of oocytes that had progressed to
MII or the size of oocytes between the two treatment groups
(Fig. 11A). Additionally, the percentage of oocytes with
tubulin scatter at MI was not significantly different (Figs. 11B
and E), indicating that the oocytes ovulated in adult animalswere of similar quality, irrespective of neonatal treatment.
These data suggest that the loss of follicles during the highly
dynamic prepubertal time frame is an active, not passive,
process of sorting the available follicles and eliminating those
of poor quality. This ‘sensing’ mechanism would therefore
allow every animal to reach puberty with the best possible
142 S.K. Bristol-Gould et al. / Developmental Biology 298 (2006) 132–148cohort of follicles, independent of hormonal or environmental
changes that might occur during the critical period of time
surrounding germline cyst breakdown and follicle assembly.
Additionally, these results are consistent with the idea of anintrinsic optimal follicle number, an ideal quantity of oocytes
that is generated from the finite germline cyst. If this ideal
threshold of follicles is exceeded, it appears to be detrimental
to gamete quality.
Fig. 10. SSEA-1 and BCL-2 immunohistochemistry on postnatal day 2. Postnatal day 2 ovaries were immunostained to detect stem cell marker SSEA-1 and the cell
survival factor BCL-2. No SSEA-1 protein was detected in vehicle-treated (A) or rh-ActA-treated (B) ovaries at this age. BCL-2 protein was detected at similar levels
within the oocyte cytoplasm in both treatment groups, (C) vehicle-treated and (D) rh-ActA-treated. Rh-ActA oocytes appeared smaller in panel D, but measurements
indicated that oocyte size was similar to that of vehicle-treated animals (p<0.05).
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under vehicle and rh-ActA treatment conditions
To gain insight into the parameters that control the formation
and persistence of the initial follicle pool, a mathematical model
was used to simulate germ cell fate through postnatal day 19.We
then explored the change in kinetic constants when specific
outcomes were altered by addition of hormone. A detailed
description of the mathematical modeling can be found in the
Materials and methods section.
A set of first-order differential equations was developed to
simulate the potential fates of the initial pool of germ cells
(Fig. 12). Eq. (1) describes (i) loss by either germ cell lysis/
phagocytosis (Franchi and Mandl, 1962) or escape from the
ovary (Hiura and Fujita, 1977; Motta and Makabe, 1986;
Wordinger et al., 1990) (kL); (ii) formation of primordial
follicles (kF); or (iii) expansion of the germ cell pool by
proliferation of germ cells or recruitment of stem cells (kE).
These germ cell counts were coupled with the follicles
formed (kF) and lost due to atresia (kA) (Eq. (2)). The
equations were solved numerically, applying boundaryFig. 9. Ovarian apoptosis and cell proliferation in vehicle and rh-ActA-treated anima
treatment groups. Apoptotic oocytes were FITC labeled whereas cells not undergoing
animals and (B, F–H) ovaries from rh-ActA-treated animals were collected on postna
(I–P) Levels of ovarian PCNA staining were higher in rh-ActA-treated animals. (I, K
treated animals were collected on postnatal day 2 following 48 h of injections. In ve
ActA-treated ovaries, 8-fold more oocytes were PCNA positive (white boxes). There w
animals compared with vehicle-treated animals (white arrows). Insets located in panel
vs. granulosa cell) were distinguished for counting purposes. The germ cells (green
cells. Scale bars: 50 μm (A, B, I, J) and 25 μm (C–H, K–P).conditions for germ cell and follicle number from our
counting data through postnatal day 6 and observations
from previous studies (Pepling and Spradling, 2001) to
determine the various kinetic constants (see Table 2 for
complete boundary conditions).
Simulations of germ cell depletion from postnatal days 0 to 6
were performed in two time intervals based on the character-
istics of germ cell loss previously described (Pepling and
Spradling, 2001). The first interval ranges from postnatal days 0
to 3, during which germ cells are lost or form follicles
(represented by the kL and kF terms, respectively). An additional
term (kE) was included to account for the possibility of germ cell
proliferation and expansion of the germ cell pool. For vehicle-
treated animals, PCNA staining indicated approximately 4.8%
germ cell proliferation at day 2, which corresponds to a kE of
0.023 days−1. The second interval ranges from postnatal days 3
to 6, during which germ cell loss is essentially completed
(Pepling and Spradling, 2001), and therefore kL was assumed to
be 0. During this time frame, the remaining germ cells form
follicles; the rate kF was assumed to be constant for the entire
postnatal days 0–6 time period. During the postnatal days 0–6ls. (A–H) Levels of apoptosis (detected by TUNEL) were not different between
DNA fragmentation were DAPI labeled. (A, C–E) Ovaries from vehicle-treated
tal day 2 following 48 h of injections. White boxes indicate dual-labeled oocytes.
–M) Ovaries from vehicle-treated animals and (J, N–P) ovaries from rh-ActA-
hicle-treated animals, little PCNA staining was noted in oocytes, whereas in rh-
as a 2-fold increase in somatic cell proliferation in ovaries from rh-ActA-treated
s K and N are monochrome images illustrating how the two cell types (germ cell
asterisks) are rounder, larger cells compared to the flattened, smaller granulosa
Fig. 11. In vivo ovulation and spindle characteristics. (A) On postnatal day 24, rh-ActA-treated animals stimulated to ovulate released significantly more oocytes
compared with vehicle-treated animals. However, the oocytes that were ovulated from rh-ActA-treated animals were significantly less mature, as indicated by the
percentage that progressed to MII. At postnatal day 57, no differences were observed in the number of oocytes ovulated or the percentage of MII oocytes. n=number of
animals. (B) Oocytes were immunostained for α-tubulin, an indicator of oocyte health status, and scored based on organization of the meiotic spindle. On postnatal day
24, the rh-ActA-treated animals had significantly more MI and MII oocytes with a scattered tubulin phenotype (n=119 oocytes for rh-ActA, n=68 oocytes for
vehicle). The percentage of oocytes with this phenotype was not significantly different between treatment groups at postnatal day 57 (n=36 oocytes for rh-ActA, n=57
oocytes for vehicle). *Significantly different p<0.05. (C–E) Examples of spindle morphology, green (α-tubulin), blue (DAPI). (C) MI oocyte spindle from a vehicle-
treated animal on postnatal day 24. (D) MI oocyte spindle from a rh-ActA-treated animal on postnatal day 24. Tubulin is scattered from the barrel shaped spindle. (E)
MI oocyte spindle from a rh-ActA-treated animal on postnatal day 57 with organized tubulin. Scale bars: 10 μm.
Fig. 12. Mathematical model of germ cell and follicle dynamics. From postnatal days 0 to 3, germ cells undergo three processes; germ cell expansion (kE), follicle
formation (kF) or loss from the ovary (kL). Throughout the next 3 days loss subsides and most germ cells complete the transition into primordial follicles, most likely
due to pre-granulosa cell invasion. By day 6, after establishment of the initial follicle pool and subsequent growth, larger follicles are depleted from the ovary by a
process termed atresia (kA). *Significantly different, p<0.05.
144 S.K. Bristol-Gould et al. / Developmental Biology 298 (2006) 132–148
Table 2
Boundary conditions for mathematical model
Germ cell pool Follicle pool
G(day 0)=G° (1) F(day 0)=0
G(day 6)=0.1×(F°/0.9) (2) F(day 6)=F° (3)
(1) Derived from in Table 1.
(2) Based on the previous report that approximately 90% of germ cells at
postnatal day 6 have already formed individual follicles (Pepling and Spradling,
2001).
(3) Derived from Tables 1 and 2.
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that kA was set to zero.
Simulation of germ cell depletion in rh-ActA-treated animals
from postnatal days 0 to 6 were performed using the same time
intervals as described for vehicle-treated animals. Using the
experimental observation that germ cell apoptosis was similar in
the absence or presence of rh-ActA, and assuming that follicle
formation rates (although not absolute numbers) would be
analogous between vehicle- and rh-ActA-treated animals, it was
found that kE alone was able to account for the differences
between the treatment groups. kE was determined to be
0.163 days− 1 for the postnatal days 0–3 period, which
corresponds to a 38.6% increase in germ cell numbers on
postnatal day 2 in the absence of concurrent mechanisms for
germ cell loss or follicle formation. This model-derived
percentage of germ cell expansion is consistent with the
experimentally derived 40.4% PCNA-positive germ cells
observed at postnatal day 2. The correlation between the
predicted value of kE and the extent of germ cell mitosis shown
by PCNA staining further suggests that the germ cell pool
expands through proliferation and not recruitment of germline
stem cells to the neonatal ovary.
As the animals approached puberty, differences in the total
follicle pool between vehicle- and rh-ActA-treated mice
disappeared, with similar numbers of primordial and advanced
follicles observed at postnatal day 19. As described above, we
hypothesized that the ovary actively eliminates excess follicles
in order to meet a pre-determined optimal number by puberty,
which is necessary for adult fertility. This depletion of the
initial follicle pool was modeled as a first-order process (Fig.
12; Eq. (2)) using total follicle counts from postnatal days 6,
10 and 19. Importantly, the assumption of a first-order process
provides that the rate of follicle loss is dependent upon follicle
number and is therefore not constant with time. Values for the
follicle atresia kinetic parameter (kA) were significantly greater
for rh-ActA-treated animals; the kinetic constant for follicle
atresia increased by 62.8% in rh-ActA-treated animals relative
to vehicle during the prepubertal period (p<0.05). This vali-
dated our prediction that rh-ActA animal ovaries eliminate
follicles at a faster rate, possibly to achieve an ideal number of
follicles by puberty.
Discussion
The mechanisms governing follicle development in the
adult require the interplay of hormones and growth factors thatorchestrate oocyte maturation, somatic cell differentiation and
follicular recruitment. In contrast, the factors and mechanisms
that manage neonatal follicle assembly and development are
less understood. These studies provide new insight into the
dynamics of postnatal follicle formation in the prepubertal
mouse. First, germline cyst breakdown is a regulated process
that can be modulated by exogenous activin. Rh-ActA
stimulated both germ cell and granulosa cell proliferation,
resulting in an approximate 30% expansion of the primordial
follicle pool. Though prepubertal animals treated with rh-
ActA ovulated 53% more oocytes, they were of poorer quality
than those ovulated by vehicle-treated animals. Despite the
initial increase in follicle numbers, there were no differences
between treatment groups in the number of ovulated follicles,
oocyte quality or litter size in adult animals (2 months old).
We propose that an initial follicle pool is established at birth,
from which the final follicle pool of puberty is selected. The
mechanism(s) governing this previously unrecognized process
of prepubertal follicle quality control may be directly re-
gulated by follicle number and oocyte health. When the initial
follicle pool number is exceeded and oocyte quality declines,
the ovary actively eliminates the excess poor quality oocytes
through increased atresia. We propose that this permits the
animal to enter puberty with an optimal number of high
quality eggs.
The effect of activin on postnatal germ cell mitosis: residual
oogonia hypothesis
In addition to stimulating proliferation of the somatic cell
compartment, activin also dramatically increased germ cell
proliferation on postnatal day 2 based on PCNA detection. It
has generally been accepted that the process of germ cell
mitosis is completed and followed by meiosis in the embryonic
mouse (Bullejos and Koopman, 2004; Evans et al., 1982;
Pepling and Spradling, 1998; Zuckerman, 1951). Therefore, by
the time of birth, the majority of oocytes are thought to be
arrested in diplotene of meiotic prophase (Evans et al., 1982;
Tam and Snow, 1981). For the majority of oocytes this is true;
however, there is a small percentage of oogonia that have not
entered meiosis by the time of birth. We found a baseline
proliferation rate of 4.8% in germ cells of vehicle-treated
animals (similar to studies in the hamster; Arrau et al., 1981). In
other words, approximately 95% of germ cells enter the final
stage of meiotic arrest. Intrigued by this observation, we
considered the idea that the remaining 5% of proliferating
oogonia could be considered stem cells as proposed in previous
studies (Johnson et al., 2004, 2005). However, immunostaining
with the stem cell marker SSEA-1 provided no evidence that
any cells in the neonatal ovary had stem-cell properties.
Instead, our data are in agreement with a study in the human
fetus, which demonstrated that germ cells that have not yet
entered meiosis are mitotically active and that germ cell mitosis
continues as other arrested oocytes form primordial follicles
(Fulton et al., 2005).
Entry into meiosis occurs in a wave-like fashion in mouse
embryonic ovaries. This process is not only dynamic, it is
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cally, cells in the rostral portion of the gonad enter meiosis
around 13.5 dpc, and meiosis continues to the caudal portion of
the ovary over at least the next 48 h. Thus, there is a spatial
distribution of the germ cells in the ovary, and we hypothesize
that by birth, a small percentage of oogonia have not yet
detected or received the signals to enter meiosis whereas other
oocytes have already entered meiotic arrest. Because a subset of
oogonia is still entering meiosis even at the time of birth, we
predict that a cohort of ‘residual’ oogonia may be the target of
activin's proliferative actions.
Clearly additional studies are necessary to determine exact
percentages of mitotic oogonia vs. meiotic oocytes within the
whole ovary in late gestation and the early neonatal period using
additional mitotic markers. PCNA is a marker of DNA
replication and widely used for the detection of cell proliferation
(Gerdes et al., 1983; Hall and Levison, 1990). However, inten-
sity and thus detection of PCNA expression shows variability
according to antibody concentration (McCormick et al., 1993).
Therefore, other investigators have used phosphorylated histone
H3 to mark mitotic germ cells in the human fetus (Brenner et al.,
2003; Fulton et al., 2005). Histone H3 becomes phosphorylated
on serine 10 during chromosomal condensation at prophase and
is dephosphorylated during telophase (Gurley et al., 1978;
Nowak and Corces, 2004). Preliminary immunostaining with
this antibody was performed on postnatal day 0 mouse ovaries
(Bristol-Gould, unpublished data). A few germ cells per ovarian
section were immunopositive for phosphorylated histone H3,
but a more quantitative analysis needs to be conducted in
addition to co-localization with a germ cell specific marker.
Postnatal loss of oogonia and oocytes via a non-apoptotic
mechanism
Of much interest is whether or not oocytes are lost from the
ovary via “programmed” cell death or if oocytes die via
mechanisms we are unable to detect using conventional
methods. High levels of cell loss are measured in the neonatal
and prepubertal ovary, but surprisingly, the mechanism of action
remains a mystery. The highest frequency of apoptotic cells in
the ovary is observed around the time of birth (Baker, 1963;
Beaumont and Mandl, 1962; Borum, 1961). Pepling et al. also
observed cell apoptosis, particularly in the ovarian outer cortex,
prior to the time of cyst breakdown. However, the frequency of
labeled germ cells was relatively low compared with the total
percent of germ cell loss over the period (Pepling and Spradling,
2001). Almost all germ cell number loss take place during cyst
breakdown; consequently, it is puzzling why so few apoptotic
germ cells were observed in our study. We predicted that one
mechanism by which rh-ActA increased the number of
primordial follicles was by decreasing the amount of apoptosis
occurring during cyst breakdown and subsequently rescuing
germ cells that would otherwise be destined for death. This
process was not proven experimentally, however.
A few scenarios may explain the high loss of germ cells
without a commensurate correlation to apoptotic markers. First,
germ cell death markers may only be expressed for a limitedperiod of time, such that labeling using traditional methods may
not detect a transient cohort that has a short residence time
(Pepling and Spradling, 2001). Secondly, it is possible that only a
fraction of cells within a cyst undergo programmed cell death, the
rest die by an alternate mechanism. Third, it has been proposed
that germ cells differentiate and become specialized nurse cells
that provide assistance to oocytes destined to be encapsulated—
in this scenario, the germ cells “disappear” but do not die
(Pepling and Spradling, 2001). Finally, germ cells may die via
apoptotic mechanisms but are rapidly cleared from the ovary so
that the number of apoptotic cells detected severely under-
estimates the number of cells that die. These possibilities are
worth exploring because germ cell and oocyte loss in the female
neonatal mouse is likely a developmentally regulated process
distinct from follicular atresia that occurs in the adult animal.
The ‘ovarian quorum sensing’ mechanism
Introduction of exogenous rh-ActA into neonatal animals
altered the intrinsic constant for germ cell expansion (kE). Rh-
ActA caused a significant amount of germ cell proliferation and
we were able to determine kE to be 0.163 days
−1 for the
postnatal days 0–3 period, which corresponds to a 38.6%
increase in germ cell numbers observed on postnatal day 2. This
increase in germ cell number resulted in an increased number of
primordial follicles counted on postnatal days 6 and 10 in
ovaries from rh-ActA-treated animals; however, by day 19
primordial follicle numbers were similar between rh-ActA- and
vehicle-treated groups. We predict that hormonal intervention
with activin A altered follicle kinetics by triggering a sense and
response mechanism within the ovary that is necessary for
maintaining follicle homeostasis and fertility.
We propose that the oocyte sensing ability of the prepubertal
ovary is necessary to normalize the follicle cohort by the time of
puberty. This mechanism ‘counts’ the number of follicles
present. If the follicle number has exceeded a specific threshold
or optimal number, atresia is triggered to rid the ovary of the
excess follicles. There is evidence of this phenomenon in mice
that overexpress BCL-2. These transgenic animals have an
increased number of primordial follicles at birth that is not
preserved in later stages of postnatal life (Flaws et al., 2001).
Using total follicle counts for our treated animals on postnatal
days 6, 10 and 19 and solving for the rate of atresia, we
determined that the value for the rate of follicular atresia was
significantly greater for rh-ActA-treated animals (p<0.05). This
suggests that the ovaries of rh-ActA-treated animals eliminated
excess follicles to a greater degree than did the ovaries of
vehicle-treated animals in order to meet a pre-determined
follicle quota by puberty that is necessary for adult fertility.
Indeed, this ‘correction’ by the ovary to restore oocyte quality
and maintain fertility in the rh-ActA perturbed animals could
suggest that either (i) there is an intrinsic compensation within
the ovary in response to increased follicle burden which
preserves good quality gametes or (ii) the size of the initial
follicle pool is of little importance, as might be suggested from
the reported existence of germline stem cells (Johnson et al.,
2004, 2005).
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quantity of healthy oocytes that can be generated from the finite
germline cyst. If this threshold is exceeded, it occurs at the
expense of gamete quality/health. Rh-ActA-treated animals had
slightly more tertiary, but significantly more antral follicles on
postnatal day 19 (Table 1). These follicles appeared to be more
responsive to recruitment by administration of gonadotropins.
Activin has been shown to stimulate FSH receptor expression,
and one possible model for the greater follicle selection seen in
rh-ActA-treated mice is that exogenous activin administration
may have stimulated FSH receptor content in the developing
follicles such that they are more sensitive to the actions of
PMSG administered during IVO (Knight and Glister, 2003).
Regardless of an increase in FSH responsiveness, though, the
oocytes within these follicles were of poorer quality compared
with those ovulated by mice treated with vehicle. Oocytes from
rh-ActA-treated mice had smaller diameters, were less mature
as indicated by the number that progressed to MII and had
spindle malformations. We believe that once the follicle quota
was exceeded in rh-ActA-treated animals, as indicated by the
number of oocytes induced to ovulate, oocyte quality
diminished.
Taken together, we conclude that the loss of follicles during
the highly dynamic prepubertal time frame is an active, not
passive, process necessary for sorting the available follicles and
eliminating those in excess. Through this mechanism, oocyte
quantity and quality are regulated, such that the suboptimal
oocytes present prior to puberty in rh-ActA-treated mice are
eliminated, and oocyte quality and fertility are restored by
2 months of age. Such a mechanism for protecting cohorts,
within the initial follicle pool, from insult would be critical for
adult fertility if this pool is the only source of gametes for
fertility. Results in the companion paper (Bristol-Gould et al.,
this issue) suggest that the initial pool is a sufficient supply of
follicles necessary for a lifetime of fertility in the mouse.
Therefore, our results indicate that a major drive of the
reproductive system is to preserve and extend fertility in order
to maximize the opportunity of each animal to place progeny in
the future.
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